<DOC>
	<DOCNO>NCT00257049</DOCNO>
	<brief_summary>The purpose study evaluation safety effectiveness levofloxacin , antibiotic , compare ceftriaxone sodium cefuroxime axetil treatment adult pneumonia .</brief_summary>
	<brief_title>A Study Safety Effectiveness Levofloxacin Compared With Ceftriaxone Sodium Cefuroxime Axetil Treatment Adults With Pneumonia</brief_title>
	<detailed_description>This randomize , open-label , parallel group , multicenter study determine safety effectiveness levofloxacin ( 488 mg daily mouth 500 mg administer intravenously daily 7 - 14 day ) compare ceftriaxone sodium ( 1 - 2 gram administer vein muscle daily divide dos twice daily 7 - 14 day ) cefuroxime axetil ( 500 mg mouth twice daily 7 - 14 day ) adults community-acquired pneumonia . The study consist 4 visit : one visit screen enrollment , 3 visit assessment safety effectiveness ( one visit Day 2 - 4 [ on-therapy ] , one visit [ post-therapy ] 5 - 7 day last dose study drug , one visit [ post-study ] 21 - 28 day last dose study drug ) . The total duration patient participation study approximately 6 week . Levofloxacin antibacterial agent use treatment many type infection adult . The purpose study compare safety effectiveness levofloxacin frequently use antibiotic ( ceftriaxone sodium cefuroxime axetil ) treatment adult pneumonia acquire community . The primary efficacy assessment clinical response 5 - 7 day last dose study drug , ( categorize cure , improve , fail ) base upon change sign symptom , change x-ray finding , Safety evaluation ( incidence adverse event , physical examination , laboratory test ) perform throughout study . Cost-effectiveness also assess study drug . The study hypothesis treatment levofloxacin least effective ceftriaxone sodium cefuroxime axetil treat patient pneumonia acquire community , well tolerate . Levofloxacin 488 mg mouth daily 500 mg intravenously daily ; ceftriaxone sodium ( 1 - 2 gram administer vein muscle daily divide dos twice daily ) ; cefuroxime axetil ( 500 mg mouth twice daily ) . Treatment duration 7 - 14 day .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Cefuroxime axetil</mesh_term>
	<mesh_term>Cefuroxime</mesh_term>
	<criteria>Diagnosis pneumonia base upon clinical sign symptom low respiratory tract infection include least 2 follow : fever , cough , greenishyellow mucus produce coughing , chest pain , shortness breath , evidence decrease lung function physical examination chest xray finding consistent acute pneumonia previously receive antibiotic pneumonia duration therapy &lt; = 24 hour , great 24 hour , without improvement stabilization therapy . Previous allergic serious adverse reaction antibiotic similar use study penicillin collection pu cavity lung membrane surround cystic fibrosis lung infection due fungus , bacteria , virus know prior start study resistant study drug severe kidney failure , decrease white blood cell count , seizure disorder , unstable psychiatric condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Pneumonia</keyword>
	<keyword>lung inflammation</keyword>
	<keyword>bacterial pneumonia</keyword>
	<keyword>lung disease</keyword>
	<keyword>respiratory tract infection</keyword>
	<keyword>antibacterial agent</keyword>
	<keyword>quinolones</keyword>
	<keyword>levofloxacin</keyword>
</DOC>